affinity maturation

Affinity maturation occurs during a T-cell dependent humoral immune response within the germinal centers of secondary lymphoid organs (lymph nodes, spleen). After initial activation, B cells proliferate rapidly (dark zone of germinal center) and undergo somatic hypermutation (SHM) mediated by activation-induced cytidine deaminase (AID), which introduces point mutations into the variable regions of immunoglobulin heavy and light chain genes—particularly in the complementarity-determining regions (CDRs) responsible for antigen binding. These mutated B cells then migrate to the light zone, where they compete for limited antigen displayed on follicular dendritic cells and for T follicular helper (Tfh) cell signals (e.g., CD40L, IL-21). B cells expressing B-cell receptors with higher affinity for antigen more effectively capture antigen, process and present it to Tfh cells, and receive stronger survival/proliferation signals. Lower-affinity clones fail to receive sufficient survival signals and undergo apoptosis. This iterative cycling between dark and light zones over days to weeks selects for B cell clones with increasingly higher-affinity receptors. Selected high-affinity B cells can differentiate into long-lived plasma cells (secreting high-affinity antibody) or memory B cells, contributing to a more robust and specific secondary immune response upon re-exposure to antigen. Class switch recombination (CSR), also AID-dependent, often occurs concurrently, allowing the antibody isotype to change (e.g., IgM to IgG) while retaining the improved antigen specificity. Clinical relevance: Defects in AID (as in hyper-IgM syndrome type 2) impair both somatic hypermutation and class switching, leading to elevated IgM and low IgG/IgA/IgE, with recurrent infections. Affinity maturation is also central to vaccine design (booster doses enhance affinity maturation) and to understanding the effectiveness of neutralizing antibodies in infections like influenza and HIV.